FTC goes after drug middlemen for allegedly jacking up insulin prices

The Big Three handle at least 80% of the country’s insulin prescriptions.

The price of insulin has exponentially increased in recent years. Now, the Federal Trade Commission (FTC) is suing three companies over allegedly inflating the cost of the drug at the expense of Americans who rely on it.